हिंदी
PrepZen Daily Current Affairs & Exam Desk
SCIENCE & TECHNOLOGY CA

Merck licenses investigational monthly HIV-prevention medicine

Merck licenses investigational monthly HIV-prevention medicine
Representative image · Photo: Pöllö / Wikimedia Commons · CC BY 3.0
Merck announced royalty-free voluntary licensing agreements for alimatravir, also called MK-8527.
The once-monthly oral medicine is being studied for HIV pre-exposure prophylaxis and remains investigational.
The access plan involves seven manufacturers, including Aurobindo Pharma, Cipla, Emcure Pharmaceuticals and Viatris; licensing is distinct from regulatory approval.

Key Facts / Static GK

PrEP: Pre-Exposure Prophylaxis.
HIV: Human Immunodeficiency Virus.
Merck is known as MSD outside the United States and Canada.

Practice Quiz — 28 July 2026

Q1. Merck's alimatravir (MK-8527) is being studied as a monthly oral medicine for what?

Full quiz for 28 July 2026

A LITTLE PRACTICE. EVERY DAY.

Turn your reading into practice.

Daily current affairs, quizzes, vocabulary and a mistake bank — together in PrepZen.

Free Android app · Learn at your own pace

STAY IN THE STUDY LOOP

Good notes. One tap away.

Find study reels, PDF keywords and current affairs updates from PrepZen.

LEARNING DOESN'T STOP HERE

Your daily study circle.

Study notes, quick revision and practice.
Choose where you follow PrepZen.